TRYPTANTHRIN DERIVATIVES WITH THIOSEMICARBAZONE SUBSTITUTION AND USE THEREOF

Abstract: the invention relates to tryptanthrin derivatives with thiosemicarbazone substitution of the general formulae i and ii, where r1-r8 are independently h, oh, alkyl with 1 to 6 carbon atoms, c(ch), allyl, propargyl, ben-zyl, phenyl, f, cl, br, i, choh, o (alkyl), cf, ocf, cn, cooh, coo(alkyl), conh, conh(alkyl), no, n(alkyl), nh(alkyl), nhco(alkyl), where the alkyl has 1 to 6 carbon atoms, or r1-r2 or r2-r3 or r3-r4 or r5-r6 or r6-r7 or r7-r8 is —ch═ch—ch═ch—, i.e., a fused benzene ring, x and z are independently h, alkyl of 1 to 6 carbon atoms, benzyl or phenyl. the compounds combine a structural motif suitable for plpro targeting, have strong affinity and selectivity for rna over dna, and at the same time effectively chelate ferric and ferrous ions. thus, these compounds have the desired properties for potential use as inhibitors of the production of sars-cov-2 viral particles and can thus be used for the preparation drugs for the treatment of coronavirus diseases, especially covid-19.

Inventor(s): Zdenek KEJIK, Robert KAPLANEK, Katerina VESELA, Karel SMETANA, Lukas LACINA, Pavel MARTASEK, Milan JAKUBEK

CPC Classification: C07D487/04 (Ortho-condensed systems)

Search for rejections for patent application number 20250171449